Medicine and Dentistry
Alveolar Macrophage
33%
Bleomycin
50%
Bleomycin-Induced Pulmonary Fibrosis
16%
Combination Therapy
16%
Efferocytosis
16%
Enhancer Region
16%
Factor X
16%
Fibroblast
16%
Hydroxyproline
16%
Infusion
100%
Interleukin 10
16%
Lung
50%
Mesenchymal-Epithelial Transition
33%
Messenger RNA
16%
Peroxisome Proliferator Activated Receptor
16%
Pneumonia
16%
Pulmonary Fibrosis
100%
Scatter Factor
16%
Statin
16%
Trichrome
16%
Type 2 Epithelial Cell
16%
Immunology and Microbiology
Alveolar Macrophage
100%
Efferocytosis
50%
Enhancer Region
50%
Epithelial Mesenchymal Transition
100%
Fibroblast
50%
Hepatocyte Growth Factor
50%
Interleukin 10
50%
Pulmonary Inflammation
50%
Type 2 Epithelial Cell
50%
Pharmacology, Toxicology and Pharmaceutical Science
Bleomycin
50%
Bleomycin-Induced Pulmonary Fibrosis
16%
Blood Clotting Factor 10
16%
Combination Therapy
16%
Hydroxyproline
16%
Interleukin 10
16%
Lung Fibrosis
100%
Messenger RNA
16%
Peroxisome Proliferator Activated Receptor
16%
Pneumonia
16%
Scatter Factor
16%
Simvastatin
100%
Statin (Protein)
16%
Biochemistry, Genetics and Molecular Biology
Alveolar Macrophage
33%
Bleomycin
66%
Efferocytosis
16%
Enhancer Region
16%
Factor X
16%
Fibroblast
16%
Hepatocyte Growth Factor
16%
Interleukin 10
16%
Mesenchymal-Epithelial Transition
33%
Messenger RNA
16%
Peroxisome Proliferator-Activated Receptor
16%
Simvastatin
100%
Statin
16%
Chemistry
Antifibrotic
33%
Apoptotic
100%
Bleomycin
44%
Enhancer
11%
Hepatocyte Growth Factor
11%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Hydroxyproline
11%
Messenger RNA
11%
Simvastatin
100%